TGM2 and ovarian carcinoma: Since the VA4 TG2 inhibitor decreased cell invasion in the OV1946 cells and these cells have previously been used to develop a xenograft model (30), we assessed whether the TG2 inhibitors could prolong survival in the OV1946 and SKOV3 ovarian cancer xenograft models.